GENE ONLINE|News &
Leqembi Makes History as First EU-Approved Drug to Target Root Cause of Alzheimer’s Disease
Eisai Co., Ltd. and Biogen Inc. announced that the European Commission (EC) has granted Marketing Authorization (MA) in the European Union (EU) for Leqembi (lecanemab), …
GO Prime with only $1.49 now
LATEST
NUS Researchers Use Evolutionary Biology Models to Map Singapore Shophouse Architectural Development
2026-08-11
City St George’s Launches €6 Million REMADE Project to Advance Circular Renovation in Urban Neighborhoods
2026-08-10
Digital Science Releases Two Model Context Protocol Servers for Dimensions Research Platform
2026-08-10
EVENT
2026-10-20
AusBiotech 2026 (20-23 Oct, Queensland) (Australia biotech & investment)
Queensland, Australia
